XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Fair value of options assumptions
                    
   Weighted
Average,
June 30,
2022		   Range,
June 30,
2022		   Weighted
Average,
June 30,
2021		   Range,
June 30,
2021		 
Volatility   65%   65% -69%   65%   58%-65%
Dividend yield   —      —      —      —   
Risk-free interest rate   2.99%   1.71% – 3.01%   0.79%   0.47%-0.82%
Expected term (years)   3.71    3.04 to 3.72    5.8    5.0 to 5.9 
Schedule of option activity
                      
    Options   Weighted-
Average
Exercise
Price		   Weighted-
Average
Remaining
Contractual
Life		   Aggregate
Intrinsic
Value		 
 Outstanding at July 1, 2020    9,511,600   $.74    4.5   $—   
   Granted    960,000    1.10           
   Exercised    —      —             
   Forfeited    —      —             
   Expired    —      —             
 Outstanding at June 30, 2021    10,471,600   $0.77    3.7   $6,064,335 
   Granted    730,000    1.00    3.7    —   
   Exercised    —      —             
   Forfeited    —      —             
   Expired    —      —             
 Outstanding at June 30, 2022    11,201,600   $0.80    2.7   $4,429,263 
Schedule of non vested stock options
            
    Options   Weighted Average
Grant-Date Fair
Value		 
 Nonvested at July 1, 2021    —     $—   
 Granted    730,000    .574 
 Vested    (730,000)   (.574)
 Nonvested at June 30, 2022    —     $—   
Condensed Financial Statement
          
   Year
ended
June 30,
2022		   Year
ended
June 30,
2021		 
General and administrative:          
  Change in fair value from modification of
    option terms		  $—     $8,775 
Change in fair value from modification of
    warrant terms		   8,337    25,506 
  Fair value of stock options expensed   261,258    816,050 
     Total  $269,595   $850,331 
           
Research and development:          
  Fair value of stock options expensed  $22,464   $201,650 
     Total  $22,464   $201,650